Tag: Rafarma

Rafarma Launched Two New Oncology Products

At the beginning of 2019, Rafarma JSC launched the first anticancer drugs Rozustin® (INN Bendamustin) and Pemelan® (INN Pemetrexed) in its own portfolio. Rosustin® for leukemia treatment has become th...

7.85 billion rubles will be invested to develop Rafarma

Protek has bought up 40 thousand shares totaling 7.825 billion rubles, that were newly issued by Rafarma, a Lipetsk-based pharmaceutical manufacturer